PMID: 16506634Mar 2, 2006Paper

Locoregional therapies for glioma

Oncology
Adam N Mamelak

Abstract

Glioma is the most common form of primary brain tumor, as well as the most lethal. Primary treatment strategies for glioma, including cytoreductive surgery, external-beam irradiation, and systemic chemotherapy have had generally disappointing results for these tumors. Limitations of these approaches include tumor invasion into functional brain tissue, lack of chemosensitivity, and shortcomings of systemic delivery. Recent attention has focused on locoregional strategies for treatment, as well as new methods for delivering therapy. Identification of tumor-specific surface targets, biologic agents, and more sophisticated means to deliver macromolecules to the brain is offering new promise in the treatment of these tumors. This paper will review the current state of the art of available locoregional therapies for glioma, with a particular focus on convection-enhanced delivery, targeted toxin, and other biologic strategies.

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
C G WillettDavid P Ryan
Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Dani S Bidros, Michael A Vogelbaum
Current Opinion in Oncology
R I Haroun, Henry Brem
Cancer Control : Journal of the Moffitt Cancer Center
M R Nowroozi, L L Pisters
© 2021 Meta ULC. All rights reserved